Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia
C. Avendaño, António Ramos, Elena Múñez, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 20
Open Access | Times Cited: 104

Showing 1-25 of 104 citing articles:

Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (September 2022)
Adarsh Bhimraj, Rebecca L. Morgan, Amy Hirsch Shumaker, et al.
Clinical Infectious Diseases (2022) Vol. 78, Iss. 7, pp. e250-e349
Open Access | Times Cited: 120
COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes
Daniele Focosi, Massimo Franchini, Liise-anne Pirofski, et al.
Clinical Microbiology Reviews (2022) Vol. 35, Iss. 3
Open Access | Times Cited: 89
High-titre methylene blue-treated convalescent plasma as an early treatment for outpatients with COVID-19: a randomised, placebo-controlled trial
Andrea Alemany, Pere Millat-Martínez, Marc Corbacho-Monné, et al.
The Lancet Respiratory Medicine (2022) Vol. 10, Iss. 3, pp. 278-288
Open Access | Times Cited: 78
Evolution of SARS-CoV-2 Variants: Implications on Immune Escape, Vaccination, Therapeutic and Diagnostic Strategies
Nur Zawanah Zabidi, Hern Liang Liew, Isra Ahmad Farouk, et al.
Viruses (2023) Vol. 15, Iss. 4, pp. 944-944
Open Access | Times Cited: 59
Efficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients
Mila B. Ortigoza, Hyunah Yoon, Keith Goldfeld, et al.
JAMA Internal Medicine (2021) Vol. 182, Iss. 2, pp. 115-115
Open Access | Times Cited: 82
Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial
Mark N. Polizzotto, Jacqueline Nordwall, Abdel G. Babiker, et al.
The Lancet (2022) Vol. 399, Iss. 10324, pp. 530-540
Open Access | Times Cited: 65
Clinical Practice Guidelines From the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 Convalescent Plasma
Lise J Estcourt, Claudia S. Cohn, Monica B. Pagano, et al.
Annals of Internal Medicine (2022) Vol. 175, Iss. 9, pp. 1310-1321
Open Access | Times Cited: 63
Pharmacological treatment of COVID-19: an opinion paper
Alberto García‐Lledó, Javier Gómez‐Pavón, Juan González del Castillo, et al.
Revista Española de Quimioterapia (2021) Vol. 35, Iss. 2, pp. 115-130
Open Access | Times Cited: 62
Convalescent plasma improves overall survival in patients with B-cell lymphoid malignancy and COVID-19: a longitudinal cohort and propensity score analysis
Thomas Hueso, Anne-Sophie Godron, Émilie Lanoy, et al.
Leukemia (2022) Vol. 36, Iss. 4, pp. 1025-1034
Open Access | Times Cited: 61
Association of Convalescent Plasma Treatment With Clinical Status in Patients Hospitalized With COVID-19
Andrea B. Troxel, Eva Petkova, Keith Goldfeld, et al.
JAMA Network Open (2022) Vol. 5, Iss. 1, pp. e2147331-e2147331
Open Access | Times Cited: 45
A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19
Yogiraj Ray, Shekhar Ranjan Paul, Purbita Bandopadhyay, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 37
Convalescent plasma for people with COVID-19: a living systematic review
Claire Iannizzi, Khai Li Chai, Vanessa Piechotta, et al.
Cochrane library (2023) Vol. 2023, Iss. 2
Open Access | Times Cited: 31
Convalescent plasma for people with COVID-19: a living systematic review
Claire Iannizzi, Khai Li Chai, Vanessa Piechotta, et al.
Cochrane library (2023) Vol. 2024, Iss. 2
Closed Access | Times Cited: 29
Mortality Rates Among Hospitalized Patients With COVID-19 Treated With Convalescent Plasma: A Systematic Review and Meta-Analysis
Jonathon W. Senefeld, Ellen K. Gorman, Patrick W. Johnson, et al.
Mayo Clinic Proceedings Innovations Quality & Outcomes (2023) Vol. 7, Iss. 5, pp. 499-513
Open Access | Times Cited: 28
Safety and Efficacy of Convalescent Plasma Combined with Other Pharmaceutical Agents for Treatment of COVID-19 in Hospitalized Patients: A Systematic Review and Meta-Analysis
Massimo Franchini, Daniele Focosi, Mario Cruciani, et al.
Diseases (2024) Vol. 12, Iss. 3, pp. 41-41
Open Access | Times Cited: 8
Convalescent plasma and predictors of mortality among hospitalized patients with COVID-19: a systematic review and meta-analysis
Massimo Franchini, Mario Cruciani, Carlo Mengoli, et al.
Clinical Microbiology and Infection (2024) Vol. 30, Iss. 12, pp. 1514-1522
Closed Access | Times Cited: 8
COVID-19 convalescent plasma
Aaron A.R. Tobian, Claudia S. Cohn, Beth H. Shaz
Blood (2021) Vol. 140, Iss. 3, pp. 196-207
Open Access | Times Cited: 47
A randomized controlled study of convalescent plasma for individuals hospitalized with COVID-19 pneumonia
Katharine J. Bar, Pamela A. Shaw, Grace Choi, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 24
Open Access | Times Cited: 40
High-Dose Convalescent Plasma for Treatment of Severe COVID-19
Gil Cunha De Santis, Luciana Correa Oliveira de Oliveira, Pedro Manuel Marques Garibaldi, et al.
Emerging infectious diseases (2022) Vol. 28, Iss. 3, pp. 548-555
Open Access | Times Cited: 33
Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants
William R. Strohl, Zhiqiang Ku, Zhiqiang An, et al.
BioDrugs (2022) Vol. 36, Iss. 3, pp. 231-323
Open Access | Times Cited: 32
Convalescent plasma (hyperimmune immunoglobulin) for COVID-19 management: An update
Vivek P. Chavda, Rajashri Bezbaruah, Sheetal Dolia, et al.
Process Biochemistry (2023) Vol. 127, pp. 66-81
Open Access | Times Cited: 16
Convalescent Plasma Therapy for COVID-19: A Systematic Review and Meta-Analysis on Randomized Controlled Trials
Charalampos Filippatos, Ioannis Ntanasis‐Stathopoulos, Kalliopi Sekeri, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 765-765
Open Access | Times Cited: 16
Use of covid-19 convalescent plasma to treat patients admitted to hospital for covid-19 with or without underlying immunodeficiency: open label, randomised clinical trial
Karine Lacombe, Thomas Hueso, Raphaël Porcher, et al.
BMJ Medicine (2023) Vol. 2, Iss. 1, pp. e000427-e000427
Open Access | Times Cited: 16
Differential efficacy and safety of anti-SARS-CoV-2 antibody therapies for the management of COVID-19: a systematic review and network meta-analysis
Jiawen Deng, Kiyan Heybati, Harikrishnaa Ba Ramaraju, et al.
Infection (2022) Vol. 51, Iss. 1, pp. 21-35
Open Access | Times Cited: 26
Safety of COVID‐19 convalescent plasma: A definitive systematic review and meta‐analysis of randomized controlled trials
Massimo Franchini, Mario Cruciani, Arturo Casadevall, et al.
Transfusion (2023) Vol. 64, Iss. 2, pp. 388-399
Closed Access | Times Cited: 12
Page 1 - Next Page

Scroll to top